(Q37947886)

25 August 2017

title

Abbreviated course of radiotherapy (RT) for breast cancer (English)

1 reference

Adaptive radiation therapy

25 August 2017

main subject

0 references

author name string

Jonathan D Schoenfeld

series ordinal

1

1 reference

25 August 2017

Jay R Harris

series ordinal

2

1 reference

25 August 2017

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

20 Suppl 3

1 reference

25 August 2017

page(s)

S116-27

1 reference

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

An overview of hypofractionation and introduction to this issue of seminars in radiation oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionation: lessons from complications

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The quality of life of early breast cancer patients treated by two different radiotherapy regimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionated Whole-Breast Radiotherapy: Impact on Departmental Waiting Times and Cost

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionated breast radiotherapy: financial and economic consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Pushing the limits of hypofractionation for adjuvant whole breast radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Clinical experience using hypofractionated radiation schedules in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionation for prostate cancer: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The implementation of ablative hypofractionated radiotherapy for stereotactic treatments in the brain and body: observations on efficacy and toxicity in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionation in adjuvant breast radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The use of a specific hypofractionated radiation therapy regimen versus classical fractionation in the treatment of breast cancer: a randomized study of 230 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Long-term results of hypofractionated radiation therapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Adjuvant Hypofractionated Radiation Therapy for Breast Cancer after Conserving Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Outcome of radiotherapy after breast conserving surgery in screen detected breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Late cosmetic results of short fractionation for breast conservation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

A shorter fractionation schedule for postlumpectomy breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Treatment of early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Management of skin toxicity during radiation therapy: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Patients' subjective evaluation of early and late sequelae in patients with breast cancer irradiated with short fractionation for breast conservation therapy: comparison with conventional fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Put the “hockey stick” on ice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Impact of fraction size on cardiac mortality in women treated with tangential radiotherapy for localized breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Radiation-induced cardiac toxicity after therapy for breast cancer: interaction between treatment era and follow-up duration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Side effects of adjuvant treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Radiation-induced Peripheral Neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Quality of life after breast radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Quantification of late complications after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Which breast cancer patients should really worry about radiation-induced heart disease--and how much?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Lung cancer after treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Breast cancer before age 40 years

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Altered fractionation: rationale and justification for whole and partial breast hypofractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Feasibility of accelerated whole-breast radiation in the treatment of patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionated Radiotherapy for Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Brachial plexopathy after postoperative radiotherapy of breast cancer patients--a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Breast radiotherapy after lumpectomy--no longer always necessary

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

The Christie Hospital breast conservation trial: an update at 8 years from inception

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Prognostic factors for local control after breast conservation: does margin status still matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Hypofractionation should be the new 'standard' for radiation therapy after breast conserving surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Skin telangiectasia: the influence of radiation dose delivery parameters in the conservative management of early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Innovations in radiation therapy (RT) for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Accelerated whole breast irradiation with intensity-modulated radiotherapy to the prone breast

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Accelerated intensity-modulated radiotherapy to breast in prone position: dosimetric results

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Non-surgical management of early breast cancer in the United Kingdom: radiotherapy fractionation practices. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

Intra-European Differences in the Radiotherapeutic Management of Breast Cancer: A Survey Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2811%2970308-3

7 January 2021

10.1016/S0960-9776(11)70308-3

Identifiers

DOI

1 reference

25 August 2017

1 reference